Tuesday, 17 November 2026 Every SEC filing alert, by company
ALFA USA Filings Every alert, straight from SEC EDGAR
News

IRulya Therapeutics Inc.

NASDAQ: IRLA · Life Sciences · 6 alerts · CIK 1662774

Share price
$37.36Close, Nov 16
Market cap
$405M
Shares outstanding
10.84MLatest SEC cover page
Sector
Life Sciences
Industry
Biological Products, (No Diagnostic Substances)SIC 2836

Today's reference numbers: shares from the company's latest SEC cover page, price from the latest market close. Not a valuation or a recommendation. All IRulya Therapeutics Inc. filings on SEC EDGAR ↗

4:58 PM ET 8-K
Stock Plan Amendment

Quince Therapeutics Stock Plan Amendment

Quince Therapeutics stockholders approved the 2026 Equity Incentive Plan and the 2026 Employee Stock Purchase Plan (ESPP) at a special meeting. The 2026 Plan has an initial reserve of 821,872 shares plus potential carryover from prior plans, while the 2026 ESPP has an initial reserve of 142,045 shares, both featuring annual evergreen increase provisions through 2036.

Get Alerts

Get ALFA Finder alerts first

Real-time SEC filing alerts for US stocks are launching soon. Leave your details and we'll tell you the moment they go live.